Article
Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
10 Apr 2014
Abstract excerpt
PURPOSE: Exosomes isolated from the plasma of newly diagnosed acute myeloid leukemia (AML) patients have elevated protein and transforming growth factor-beta 1 (TGF-β1) contents and inhibit natural killer (NK) cell cytotoxicity (Haematologica 96, p. 1302, 2011). A potential role of exosomes in predicting responses to chemotherapy (CT) was evaluated in AML patients undergoing treatment. EXPERIMENTAL DESIGN: Plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
